SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001214659-24-017999
Filing Date
2024-10-28
Accepted
2024-10-28 16:03:06
Documents
1
Group Members
OCTAGON INVESTMENTS MASTER FUND LPTING JIA

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 y1028240sc13ga1.htm SC 13G/A 67846
  Complete submission text file 0001214659-24-017999.txt   69615
Mailing Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301
Business Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301 (720) 307-2892
OnKure Therapeutics, Inc. (Subject) CIK: 0001637715 (see all company filings)

IRS No.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92480 | Film No.: 241400853
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 654 MADISON AVENUE 21ST FLOOR NEW YORK NY 10065
Business Address 654 MADISON AVENUE 21ST FLOOR NEW YORK NY 10065 212-369-2829
Octagon Capital Advisors LP (Filed by) CIK: 0001839435 (see all company filings)

IRS No.: 843576791 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A